Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,1 USD | +1,94% | -40,68% | -54,35% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Willard
CEO | Chief Executive Officer | 63 | 12/07/22 |
Jonathan Javitt
FOU | Founder | 67 | 18/09/17 |
Richard Narido
DFI | Director of Finance/CFO | 46 | 13/09/23 |
Chief Tech/Sci/R&D Officer | - | 05/12/22 | |
Rick Panicucci
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Corporate Officer/Principal | - | 01/10/15 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jonathan Javitt
FOU | Founder | 67 | 18/09/17 |
Stephen Willard
CEO | Chief Executive Officer | 63 | 12/07/22 |
Janet Rehnquist
BRD | Director/Board Member | - | 27/12 |
Patrick J. Flynn
BRD | Director/Board Member | 75 | 24/05/21 |
Chaim Hurvitz
BRD | Director/Board Member | 63 | 24/05/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 10 555 405 | 7 680 213 ( 72,76 %) | 0 | 72,76 % |
Action B | 0 | 3 000 000 | 0 | 0 |
Coordonnées société
Secteur
Chiffre d'affaires trimestriel - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
-54,35% | 21,88 M | |
+25,69% | 47,86 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,66 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+0,17% | 12,15 Md | |
+28,07% | 12,14 Md | |
-1,24% | 11,99 Md |
- Bourse
- Actions
- Action BRPA
- Société NRx Pharmaceuticals, Inc.